Voxelotor

Clinical Indication

Reducing need for transfusion in sickle cell disease

Comments

TA981

Oxbryta 500 mg film-coated tablets

Date of classification

July 2024

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.